PharmGen Science, Inc. (KRX:004720)

Market Cap	83.05B
Revenue (ttm)	171.66B
Net Income (ttm)	117.75M
Shares Out	18.62M
EPS (ttm)	6.50
PE Ratio	705.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,718,996
Average Volume	1,042,358
Open	4,870.00
Previous Close	4,745.00
Day's Range	4,580.00 - 5,080.00
52-Week Range	3,640.00 - 6,430.00
Beta	0.64
RSI	51.36
Earnings Date	Aug 14, 2025

About Verve Therapeutics

PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1957 and is headquartered in Hwaseong-si, South Korea.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1957
• Employees: 226
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 004720

Financial Performance

In 2024, PharmGen Science's revenue was 171.29 billion, an increase of 2.70% compared to the previous year's 166.78 billion. Earnings were 2.79 billion, a decrease of -54.17%.